RSV is the leading cause of infant hospitalization in the U.S.• Health officials urge vaccination for pregnant women, seniors ...

A wave of the highly contagious respiratory syncytial virus is beginning to wash over the United States, sending greater ...

More hard-to-find doses of Beyfortus, the new immunization against respiratory syncytial virus (RSV) for infants, will be available in January, the White House says. The announcement comes as RSV ...

Babies can be safely administered antibody protection against respiratory syncytial virus after birth even if their moms had ...

During the first RSV season in which a maternal vaccine and a monoclonal antibody for infants were available, 72% of infants were immunized, this study found. Disparities in access to immunization ...

Compared with placebo, single-dose clesrovimab 105 mg reduced the risk for RSV-associated LRI and hospitalization in healthy infants.

For the pediatric population, RSV is predicted to be the leading cause of hospitalizations due to a respiratory illness. This ...

WASHINGTON -- The U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against respiratory syncytial virus (RSV). The vaccine would be given ...

A vaccination programme to tackle respiratory syncytial virus (RSV) is to be extended to cover premature babies born in Northern Ireland. A long-acting injection is to be offered for eligible children ...

A successful trial conducted in 2022 on babies like Harry means all pregnant mothers are now offered the jab [BBC] Three years ago, baby Harry took part in a vaccine trial for premature babies that ...

Learn about respiratory syncytial virus (RSV), its symptoms, treatment options, and the latest RSV vaccine to protect infants ...

A new jab which offers a “protective bubble” to premature babies from a common virus is set to be rolled out by the NHS this autumn. Experts say the drug, which will be available in England, will give ...